Study: DTC ads for breast cancer drugs hit target

11/26/2012 | Medical Marketing & Media

Direct-to-consumer campaigns for three aromatase inhibitors did not spur more prescriptions for premenopausal breast cancer patients but may have increased prescriptions for postmenopausal patients, for whom the drugs are indicated, a study published in the journal Cancer found.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR